INCYTE BIOSCIENCES DISTRIBUTION B.V.

Italy

All drugs from this manufacturer

  • ICLUSIG

    It is used in adults to treat certain types of leukemia (chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia) that do not respond to other medicines or that present a specific genetic mutation (T315I).

    Dosage form: tablets, film-coated

    Active substance Dosage
    ponatinib -

    ATC: L01EA05

  • MINJUVI

    It is used for the treatment of adults with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) that have relapsed after previous treatment or have not responded to previous therapies.

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    tafasitamab -

    ATC: L01FX12

  • OPZELURA

    It is used on the skin to treat facial vitiligo in adults and adolescents aged 12 years and older.

    Dosage form: cream

    Active substance Dosage
    ruxolitinib -

    ATC: D11AH09

  • PEMAZYRE

    It is used for the treatment of adults with bile duct cancer (cholangiocarcinoma) whose tumor cells exhibit an abnormal form of the FGFR2 protein, especially when the tumor has spread or cannot be surgically removed and other medicines are no longer effective.

    Dosage form: tablets

    Active substance Dosage
    pemigatinib -

    ATC: L01EN02

  • ZYNYZ

    It is used in adults to treat squamous cell carcinoma of the anal canal (when the tumor has spread or recurred and is inoperable) and Merkel cell carcinoma (a rare skin tumor that cannot be treated with surgery or radiotherapy).

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    retifanlimab -

    ATC: L01FF10